Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia

被引：0
|
作者：
Mingot Castellano, Maria Eva [1 ]
Pedrote Amador, Begona [1 ]
Tomasello, Riccardo [2 ,3 ,4 ]
Ghanima, Waleed [4 ,5 ]
机构：
[1] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, IBIS, Serv Hematol, Seville, Spain
[2] Univ Oslo, Ostfold Hosp, Dept Res, Oslo, Norway
[3] Univ Oslo, Ostfold Hosp, Dept Haematooncol, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
[5] Univ Oslo, Ostfold Hosp, Oslo, Norway
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of romiplostim in adult Iraqi patients with refractory immune thrombocytopenia
    Jumaa, Ali
    Saleh, Tareq
    Khalaf, Asaad
    Abbas, Mohammed
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 92 - 96
  • [42] Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
    Cines, Douglas B.
    Wasser, Jeffrey
    Rodeghiero, Francesco
    Chong, Beng H.
    Steurer, Michael
    Provan, Drew
    Lyons, Roger
    Garcia-Chavez, Jaime
    Carpenter, Nancy
    Wang, Xuena
    Eisen, Melissa
    HAEMATOLOGICA, 2017, 102 (08) : 1342 - 1351
  • [43] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [44] Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia
    Virk, Zain
    Leaf, Rebecca Karp
    Kuter, David J.
    Goodarzi, Katayoon
    Connell, Nathan T.
    Connors, Jean M.
    Al-Samkari, Hanny
    BLOOD, 2023, 142
  • [45] An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia
    Song, Andrew B.
    Al-Samkari, Hanny
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (08) : 783 - 791
  • [46] Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease
    Wang, Huaquan
    He, Guangsheng
    Jia, Jinsong
    Liu, Mengyuan
    Liu, Hui
    Wang, Ting
    Liu, Chunyan
    Fu, Rong
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2023, 11 (01) : 90 - 93
  • [47] Avatrombopag/Fostamatinib/Immune-globulinHypertension, acute myocardial infarction, deep venous thrombosis and lack of efficacy: 5 case reports
    Reactions Weekly, 2024, 2028 (1) : 81 - 81
  • [48] Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program
    Duliege, Anne-Marie
    Arnold, Donald M.
    Boccia, Ralph
    Boxer, Michael
    Cooper, Nichola
    Hill, Quentin A.
    Liles, Darla K.
    Sholzberg, Michelle
    Zayed, Hany
    Tong, Sandra
    Bussel, James B.
    BLOOD, 2018, 132
  • [49] Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results
    Bussel, James B.
    Arnold, Donald M.
    Cooper, Nichola
    Khalafallah, Alhossain A.
    Boxer, Michael
    Liles, Darla
    Ghanima, Waleed
    McCrae, Keith
    Zayed, Hany
    Cadieux, Benoit
    Duliege, Anne-Marie
    BLOOD, 2017, 130
  • [50] SAFETY AND EFFICACY OF RITUXIMAB IN ADULT IMMUNE THROMBOCYTOPENIA
    Biagiotti, C.
    Carrai, V.
    Bacchiarri, F.
    Di Gioia, M.
    Raugei, G.
    Bosi, A.
    HAEMATOLOGICA, 2016, 101 : 831 - 831
12345